Study: Safety and Efficacy of the Xanomeline Transdermal Therapeutic System (TTS) in Patients with Mild to Moderate Alzheimers Disease.
Phase II
· Site: 703 (USA) (Dr. Okafor)
· consented 2013-10-17
Adverse events
4
Serious AEs
0
Open data queries
0
Luna dropout signal
–
Adverse events
mild
assessed
2026-08-18
Mild APPLICATION SITE ERYTHEMA — outcome: NOT RECOVERED/NOT RESOLVED; onset 2013-10-31 (study day 15.0); relationship: POSSIBLE
moderate
assessed
2026-08-18
Moderate APPLICATION SITE ERYTHEMA — outcome: NOT RECOVERED/NOT RESOLVED; onset 2013-10-31 (study day 15.0); relationship: POSSIBLE
mild
assessed
2026-08-18
Mild SOMNOLENCE — outcome: NOT RECOVERED/NOT RESOLVED; onset 2013-11-22 (study day 37.0); relationship: REMOTE
moderate
assessed
2026-08-18
Moderate SOMNOLENCE — outcome: NOT RECOVERED/NOT RESOLVED; onset 2013-11-22 (study day 37.0); relationship: REMOTE
Data queries
No data queries.
☾ Luna engagement
This participant doesn't use Luna.